IBDEI12X ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39188,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,39188,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,39188,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,39189,0)
 ;;=C50.912^^148^1947^131
 ;;^UTILITY(U,$J,358.3,39189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39189,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,39189,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,39189,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,39190,0)
 ;;=C50.911^^148^1947^153
 ;;^UTILITY(U,$J,358.3,39190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39190,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,39190,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,39190,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,39191,0)
 ;;=C50.919^^148^1947^123
 ;;^UTILITY(U,$J,358.3,39191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39191,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,39191,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,39191,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,39192,0)
 ;;=C62.90^^148^1947^161
 ;;^UTILITY(U,$J,358.3,39192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39192,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,39192,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,39192,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,39193,0)
 ;;=D03.9^^148^1947^165
 ;;^UTILITY(U,$J,358.3,39193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39193,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,39193,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,39193,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,39194,0)
 ;;=C45.0^^148^1947^166
 ;;^UTILITY(U,$J,358.3,39194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39194,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,39194,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,39194,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,39195,0)
 ;;=C90.01^^148^1947^168
 ;;^UTILITY(U,$J,358.3,39195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39195,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,39195,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,39195,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,39196,0)
 ;;=C90.00^^148^1947^169
 ;;^UTILITY(U,$J,358.3,39196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39196,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,39196,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,39196,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,39197,0)
 ;;=C94.6^^148^1947^170
 ;;^UTILITY(U,$J,358.3,39197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39197,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,39197,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,39197,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,39198,0)
 ;;=D61.82^^148^1947^171
 ;;^UTILITY(U,$J,358.3,39198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39198,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,39198,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,39198,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,39199,0)
 ;;=D47.9^^148^1947^172
 ;;^UTILITY(U,$J,358.3,39199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39199,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,39199,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,39199,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,39200,0)
 ;;=D53.9^^148^1947^176
 ;;^UTILITY(U,$J,358.3,39200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39200,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,39200,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,39200,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,39201,0)
 ;;=D47.4^^148^1947^177
 ;;^UTILITY(U,$J,358.3,39201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39201,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,39201,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,39201,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,39202,0)
 ;;=D59.1^^148^1947^28
 ;;^UTILITY(U,$J,358.3,39202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39202,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,39202,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,39202,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,39203,0)
 ;;=D51.3^^148^1947^191
 ;;^UTILITY(U,$J,358.3,39203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39203,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,39203,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,39203,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,39204,0)
 ;;=D77.^^148^1947^57
 ;;^UTILITY(U,$J,358.3,39204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39204,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,39204,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,39204,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,39205,0)
 ;;=D58.2^^148^1947^83
 ;;^UTILITY(U,$J,358.3,39205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39205,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,39205,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,39205,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,39206,0)
 ;;=C88.8^^148^1947^103
 ;;^UTILITY(U,$J,358.3,39206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39206,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,39206,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,39206,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,39207,0)
 ;;=D70.8^^148^1947^174
 ;;^UTILITY(U,$J,358.3,39207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39207,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,39207,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,39207,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,39208,0)
 ;;=D59.4^^148^1947^175
 ;;^UTILITY(U,$J,358.3,39208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39208,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,39208,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,39208,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,39209,0)
 ;;=D69.59^^148^1947^181
 ;;^UTILITY(U,$J,358.3,39209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39209,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,39209,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,39209,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,39210,0)
 ;;=C22.7^^148^1947^46
 ;;^UTILITY(U,$J,358.3,39210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39210,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,39210,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,39210,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,39211,0)
 ;;=D75.89^^148^1947^56
 ;;^UTILITY(U,$J,358.3,39211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39211,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,39211,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,39211,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,39212,0)
 ;;=D47.Z9^^148^1947^173
 ;;^UTILITY(U,$J,358.3,39212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39212,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,39212,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,39212,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,39213,0)
 ;;=D05.82^^148^1947^34
 ;;^UTILITY(U,$J,358.3,39213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39213,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,39213,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,39213,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,39214,0)
 ;;=D05.81^^148^1947^36
 ;;^UTILITY(U,$J,358.3,39214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39214,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,39214,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,39214,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,39215,0)
 ;;=D05.80^^148^1947^38
 ;;^UTILITY(U,$J,358.3,39215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39215,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,39215,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,39215,2)
 ;;=^5001932
